Delivery Order SPE2DB20D6035-SPE2DB24FD1RM
Award Date
2/5/24
Potential Completion Date
2/6/24
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of VYVANSE 50 MG CAPSULE 100S to the Defense Logistics Agency (DLA), with a ceiling value of $1,617.28. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and is a Delivery Order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award is for the delivery of VYVANSE 70 MG CAPSULE 100S, a prescription medication, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract has a ceiling value of $4,653.59 and is a firm fixed-price delivery order with an ultimate completion date of April 18, 2024. The contract is not set aside for any specific business type....
This federal contract award is for the delivery of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. The contract is a Delivery Order with a Firm Fixed Price of $3,798.29 and an Ultimate Completion Date of May 24, 2024....
This federal contract award is for the delivery of VYVANSE 20 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract, valued at $1,685.14, has been awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The contract is a firm fixed price delivery order with a completion date of March 1, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is an experienced provider of pharmaceutical products...
This federal contract award is for the delivery of VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The award, valued at $3,737.38, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of November 19, 2024 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the delivery of VYVANSE 50 MG CAPSULE 100S to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $1,337.70 and is a delivery order with a firm fixed price. The contract has an ultimate completion date of April 2, 2025 and was awarded on April 1, 2025. The place of performance is Conshohocken, PA....
This federal contract award is for the delivery of VYVANSE 60 MG CAPSULE 100S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on a firm-fixed-price basis with a ceiling value of $3,963.16. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of VYVANSE 20 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $1,776.74 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,692,509 units of VYVANSE 30 mg capsules. The contract has a completion date of February 20, 2024 and a potential value of $1,357.00. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order and does not have any major subcontractors noted. The contract does not have a...
This federal contract award is for the delivery of VYVANSE 70 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $1,927.45 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 24, 2025, with an ultimate completion date of January 27, 2025. The contract is not designated as a set-aside procurement. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...